Treatment with eribulin (halaven) in heavily pre-treated patients with metastatic breast cancer.
Department of Oncology, Aarhus University Hospital , Aarhus , Denmark.
Maja Lynge
ML
Rasmussen
Gabor
G
Liposits
Subethini
S
Yogendram
Anders Bonde
AB
Jensen
Søren
S
Linnet
Sven Tyge
ST
Langkjer
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D005260:Female; D005663:Furans / Q000627:therapeutic use*; D006801:Humans; D007659:Ketones / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000556:secondary; D008207:Lymphatic Metastasis; D008875:Middle Aged; D012189:Retrospective Studies; D000095662:Polyether Polyketides
D000970:Antineoplastic Agents; D005663:Furans; D007659:Ketones; C490954:eribulin; D000095662:Polyether Polyketides